Article (Scientific journals)
The role of epigenetics in malignant pleural mesothelioma
Vandermeers, Fabian; Neelature Sriramareddy, Sathyanarayana; Chrisostome, Costa et al.
2013In Lung Cancer, 81, p. 311-318
Peer Reviewed verified by ORBi
 

Files


Full Text
Vandermeers MPM review final.pdf
Publisher postprint (1.92 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Mesothelioma; Epigenetics; DNA methylation; Histone acetylation
Abstract :
[en] Malignant pleural mesothelioma (MPM) is an almost invariably fatal cancer of the pleura due to asbestos exposure. Increasing evidence indicates that unresponsiveness to chemotherapy is due to epigenetic errors leading to inadequate gene expression in tumor cells. The availability of compounds that modulate epigenetic modifications, such as histone acetylation or DNA methylation, offers new prospects for treatment of MPM. Here, we review latest findings on epigenetics in mesothelioma and present novel strategies for promising epigenetic thérapies.
Disciplines :
Oncology
Author, co-author :
Vandermeers, Fabian
Neelature Sriramareddy, Sathyanarayana ;  Université de Liège - ULiège
Chrisostome, Costa
Hubaux, Roland
Cosse, Jean-Philippe ;  Université de Liège - ULiège > GIGA-R : Epigénétique Cellulaire et Moléculaire
Willems, Luc  ;  Université de Liège - ULiège > Chimie et bio-industries > Biologie cell. et moléc.
Language :
English
Title :
The role of epigenetics in malignant pleural mesothelioma
Publication date :
2013
Journal title :
Lung Cancer
ISSN :
0169-5002
eISSN :
1872-8332
Publisher :
Elsevier Scientific, Limerick, Ireland
Volume :
81
Pages :
311-318
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
This work was supported by the “Fonds National de la Recherche Scientifique” (FNRS), the Télévie, the Belgian Foundation against Cancer, the Sixth Research Framework Programme of the European Union (project INCA LSHC-CT-2005-018704), the “Neoangio” excellence program and the “Partenariat Public Privé” PPP INCA of the “Direction générale des Technologies, de la Recherche et de l’Energie/DG06” of the Walloon government, the “Action de Recherche Concertée Glyvir” of the “Communauté franc¸ aise de Belgique”, the “Centre anticancéreux près ULg” (CAC), the “Synbiofor” project of GxABT, the “ULg Fonds Spéciaux pour la Recherche”, the “Plan Cancer” of the “Service Public Fédéral,” and the Interuniversity Attraction Poles (IAP) Program BELVIR initiated by the Belgian Science Policy Office.
Available on ORBi :
since 22 August 2013

Statistics


Number of views
79 (20 by ULiège)
Number of downloads
3 (2 by ULiège)

Scopus citations®
 
49
Scopus citations®
without self-citations
47
OpenCitations
 
37

Bibliography


Similar publications



Contact ORBi